• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

FGV Capital Closes $35M Fund II and Rebrands to Scale Platform-First Venture Model

by Fred Pennic 08/25/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know

  • FGV Capital (the venture arm of FGV, formerly known as Fiat Ventures) announced the final close of its $35M Fund II (inclusive of co-investment vehicles), oversubscribed from its initial $25M target.
  • Fund II brings the firm’s total assets under management (AUM) to more than $60 million across its early-stage investment platform.
  • Co-founded and led by Marcos Fernandez, Drew Glover, Alex Harris, and Rohit Ramkumar, the firm focuses on early-stage seed and pre-seed rounds at the intersection of financial technology, financial access, healthtech, and AI innovation.
  • Alongside the fund close, the firm unveiled a unified brand architecture, bringing growth consultancy Fiat Growth and investment arm Fiat Ventures under the single FGV umbrella brand.

Full-Stack Distribution, Institutional LP Syndicates, and AI-Driven Growth

Over the past decade, traditional venture firms raised multi-billion-dollar mega-funds, relying on financial engineering and ownership markups while outsourcing go-to-market execution to portfolio founders. However, in the current deployment phase of artificial intelligence and vertical fintech, raw capital is no longer a sustainable differentiator.

As foundation models commoditize basic software engineering, the primary failure mode for early-stage startups is no longer building a prototype—it is securing scalable distribution, acquiring customers cost-effectively, and navigating complex regulatory and capital-market partnerships.

Founders building at the intersection of financial services, healthcare, and applied AI require operating partners who can engineer defensible go-to-market pipelines directly into their commercial stack. FGV Capital’s Fund II pairs institutional capital with hands-on operational scaling across financial services and digital health:

  • Reverse-Engineered Platform Architecture: Unlike conventional funds that construct advisory services after raising capital, FGV established its growth consultancy (Fiat Growth) in 2018, having supported more than 325 companies in generating billions of dollars in revenue across D2C acquisition, B2B enterprise sales pipelines, and B2B2C distribution partnerships.
  • Institutional LP Base: Fund II brings together premier global financial institutions and strategic networks, including Reinsurance Group of America (RGA), MassMutual, Bank of America, and the Stellar Development Foundation, providing portfolio companies with direct enterprise partnership and distribution channels.
  • Integrated GTM & Strategic Finance Engine: Backed companies receive operational support spanning full-funnel performance marketing, regulatory and compliance structuring, embedded talent recruitment, and strategic fractional finance.
  • Focused Application-Layer Mandate: Targets early-stage companies applying generative AI and proprietary data models to vertical workflows—spanning embedded fintech, insurtech, financial inclusion infrastructure, and digital health.
  • Proven Portfolio Velocity: Across Fund I, Fund II, and special purpose co-investment vehicles, FGV Capital has deployed capital into over 40 startups—including Splitero, Brellium, Trellis, Sunfish, Possible Finance, and Wagmo—surpassing $60 million in total firm AUM.

“Fund I showed that our model can consistently win access to top founders and create meaningful value for them,” said Marcos Fernandez, Co-Founder and Managing Partner at FGV Capital. “With Fund II, we’re applying that approach at institutional scale. We’re leading and co-leading more rounds, structuring transactions, and demonstrating that the real winners need a partner with a differentiated platform, deep operating experience, and a relentless focus on founder outcomes.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Healthcare Venture Capital

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Redesign Health Study: 71% of Health Systems Adopt an "Epic-First" AI Purchasing Strategy

Redesign Health Study: 71% of Health Systems Adopt an “Epic-First” AI Purchasing Strategy

iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

mount-sinai-launches-epic-chart-with-art-nursing-ambient-ai

Mount Sinai Medical Center Extends Epic’s Ambient AI to Inpatient Nursing

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

Why Brain Health Is Entering Its Infrastructure Era

Brain Health’s Infrastructure Era: Proving Clinical Outcomes with Integrated Neuromotor Tracking

Why Catholic Health Inked a $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

Catholic Health Inks $500M Care Alliance with GE HealthCare to Automate Outpatient Triage

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

KLAS Global HIT Trends 2026 Report: Artificial Intelligence Becomes the Top Investment Priority

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |